[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371967-105":59,"doc-detail-371967-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","unveiling-the-znf384-ints13-hnrnpc-axis-as-a-therapeutic-vulnerability-in-cervical-cancer","Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer","","Cervical cancer persists as a major global health burden, requiring novel therapeutic targets beyond existing treatment limits. This study systematically characterizes integrator complex subunit 13 (INTS13) across cervical cancer progression using TCGA analyses and single-cell RNA sequencing. Results show INTS13 overexpression in malignant epithelial cells, association with advanced tumor stage and worse survival, and functional dependence via INTS13 knockdown/CRISPR inhibition. Mechanistically, ZNF384 drives INTS13 transcription, which regulates hnRNPC; hnRNPC restoration reverses INTS13 loss effects. In vivo xenografts confirm that INTS13 silencing restrains growth, lowers proliferation, elevates apoptosis, and reduces hnRNPC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unveiling-the-znf384-ints13-hnrnpc-axis-as-a-therapeutic-vulnerability-in-cervical-cancer/371967/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unveiling-the-znf384-ints13-hnrnpc-axis-as-a-therapeutic-vulnerability-in-cervical-cancer/371967.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-22","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study identify as the therapeutic vulnerability in cervical cancer?","Question",{"text":112,"@type":113},"The study highlights the ZNF384-INTS13-hnRNPC signaling axis, showing that INTS13 acts as a crucial factor driving malignant phenotypes and can be targeted to impede tumor progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is INTS13 expression linked to clinical outcomes in cervical cancer?",{"text":117,"@type":113},"Analysis of TCGA datasets shows INTS13 is significantly overexpressed across cervical cancer subtypes, correlates with advanced tumor T stage, and predicts poorer overall survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism connects ZNF384, INTS13, and hnRNPC?",{"text":121,"@type":113},"ZNF384 binds to and positively regulates INTS13 transcription; INTS13 then controls hnRNPC expression. Restoring hnRNPC reverses the anti-cervical cancer effects caused by INTS13 silencing.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371967,1790334340,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nUnveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer  \nJuan Wang 1,6, Shuang Liu2,6, Ping Li 3,6, Yasser Perera Negrin4,5, Fang-Rong Shen 1 ✉ and Rong Ma 2 ✉  \n© The Author(s) 2025  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Cervical cancer remains a major global health burden, necessitating the identiﬁcation of novel therapeutic targets to overcome the limitations of current treatments. Here, we comprehensively investigated the role of integrator complex subunit 13 (INTS13) in cervical cancer progression. Our analysis of publicly available The Cancer Genome Atlas (TCGA) datasets revealed that INTS13 is signiﬁcantly overexpressed in cervical cancer tissues across various histological subtypes, correlating with advanced tumor T-stage and predicting poorer overall survival. Single-cell RNA sequencing further localized INTS13 expression predominantly to malignant epithelial cells within the tumor microenvironment, where its expression correlated with genes involved in critical cellular processes. Furthermore, elevated expression has been observed in cervical cancer tissues from surgically-treated patients and in various primary human cervical cancer cells. In vitro functional studies demonstrated that genetic silencing or CRISPR/Cas9-mediated knockout of INTS13 signiﬁcantly inhibited the proliferation, migration, and invasion of primary cervical cancer cells, while selectively inducing apoptosis. Conversely, ectopic INTS13 overexpression markedly enhanced these malignant phenotypes. Mechanistically, we identiﬁed heterogeneous nuclear ribonucleoprotein C (hnRNPC) as a critical downstream effector, with INTS13 regulating hnRNPC expression, and the restoration of hnRNPC effectively reversing the anti-cervical cancer effects observed upon INTS13 silencing. Furthermore, the transcription factor ZNF384 (zinc ﬁnger protein 384) was identiﬁed as an upstream regulator that directly binds to and positively governs INTS13 expression. Finally, in vivo animal models conﬁrmed that targeted silencing of INTS13 signiﬁcantly impeded cervical cancer xenograft growth in nude mice, reduced cellular proliferation, and augmented apoptosis, consistently accompanied by a reduction in hnRNPC expression. These ﬁndings collectively establish INTS13 as a crucial precancerous gene in cervical cancer, promoting malignant phenotypes primarily through the ZNF384-INTS13-hnRNPC |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | signaling axis. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2025)16:920; [https://doi.org/10.1038/s41419-025-08374-6](https://doi.org/10.1038/s41419-025-08374-6) |  |\n|  |  |  |\n\nINTRODUCTION  \nHuman cervical cancer continues to represent a formidable global health challenge [1], standing as the fourth most frequently diagnosed cancer and the fourth leading cause of cancer-related death among women worldwide [2, 3], with an estimated over 600,000 new cases and 340,000 deaths annually [2, 3] . Cervical carcinoma exhibits diverse histological subtypes, primarily categorized into squamous cell carcinoma (SCC) and adenocarcinoma (AC), with distinct epidemiological proﬁles and clinical implications. SCC constitutes the vast majority, typically accounting for 80–90% of cases and originating from the ectocervix, often within the transformation zone [4, 5] . AC, representing 10–20% of cases, arises from the glandular epithelium of the endocervix [1, 6] . Despite substantial advancements in preventative strategies, including widespread screening programs and the application of human papillomavirus (HPV) vaccination [7], its prevalence, particularly within low- and middle-income countries, persists asa critical public health issue [1, 6] .  \nHPV is unequivocally established as the primary causative ag","cbCaisDYdFU00NM8","https://ap.wps.com/l/cbCaisDYdFU00NM8","pdf",8793097,16,"English","# Introduction\n## Cervical cancer burden and histological subtypes\n## Role of high-risk HPV in carcinogenesis\n# Results and mechanisms\n## INTS13 expression and clinical correlations\n## Single-cell localization to malignant epithelial cells\n## Functional effects of INTS13 silencing and overexpression\n## ZNF384 as upstream regulator of INTS13\n## hnRNPC as downstream effector of the INTS13 axis\n# In vivo validation\n## Xenograft growth inhibition and apoptosis changes","[{\"question\":\"What does the study identify as the therapeutic vulnerability in cervical cancer?\",\"answer\":\"The study highlights the ZNF384-INTS13-hnRNPC signaling axis, showing that INTS13 acts as a crucial factor driving malignant phenotypes and can be targeted to impede tumor progression.\"},{\"question\":\"How is INTS13 expression linked to clinical outcomes in cervical cancer?\",\"answer\":\"Analysis of TCGA datasets shows INTS13 is significantly overexpressed across cervical cancer subtypes, correlates with advanced tumor T stage, and predicts poorer overall survival.\"},{\"question\":\"What mechanism connects ZNF384, INTS13, and hnRNPC?\",\"answer\":\"ZNF384 binds to and positively regulates INTS13 transcription; INTS13 then controls hnRNPC expression. Restoring hnRNPC reverses the anti-cervical cancer effects caused by INTS13 silencing.\"}]","Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer | PDF",1790193342,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cb3979321541823738bfd092f1d8e8c.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6c90a7cb1d752cef1f0adb007fcecdd.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/913b05b0c57409bea3904e36801685a4.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb034e8199bc29efd3bde0fb9cfc86c2.webp",980,1301]